Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

12.21B

Market cap12.21B

Price-Earnings ratio

-3.77

Price-Earnings ratio-3.77

Dividend yield

—

Dividend yield—

Average volume

10.96M

Average volume10.96M

High today

$33.31

High today$33.31

Low today

$31.42

Low today$31.42

Open price

$33.19

Open price$33.19

Volume

8.51M

Volume8.51M

52 Week high

$127.20

52 Week high$127.20

52 Week low

$23.15

52 Week low$23.15

MRNA News

Simply Wall St 3d

Moderna (NasdaqGS:MRNA) Added to Russell Midcap Indexes

recently experienced significant index changes, with the company being added to the Russell Midcap and Midcap Value indexes, while being dropped from several ot...

TipRanks 5d

Moderately bullish activity in Moderna with shares up 3.95%

Moderately bullish activity in Moderna (MRNA), with shares up $1.29, or 3.95%, near $34.09. Options volume relatively light with 51k contracts traded and calls...

Benzinga 5d

FDA Grants Complete Approval To Moderna's COVID-19 Vaccine For Children As Young As 6 Months

The U.S. Food and Drug Administration (FDA) has approved Moderna Inc.’s MRNA supplemental Biologics License Application (sBLA) for Spikevax, the company’s COVID...

Analyst ratings

64%

of 28 ratings

Buy

21.4%

Hold

64.3%

Sell

14.3%

More MRNA News

Seeking Alpha 5d

Moderna wins full FDA approval for COVID shot in children

Moderna (NASDAQ:MRNA) announced on Thursday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its Spikevax COVID-19 vaccine to all...

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.